Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

The management of multiple primary cancers, an event not so infrequent in oncology practice, is a critical issue due to the lack of literature. In this study, we reported the case of a patient with non-small cell metastatic lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Oronzo, Badalamenti, Giuseppe, De Summa, Simona, Calabrese, Angela, Argentiero, Antonella, Fucci, Livia, Longo, Vito, Galetta, Domenico, Perrotti, Pia Maria Soccorsa, Pinto, Rosamaria, Petriella, Daniela, Danza, Katia, Tommasi, Stefania, Leonetti, Francesco, Silvestris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627355/
https://www.ncbi.nlm.nih.gov/pubmed/31146476
http://dx.doi.org/10.3390/cancers11060749

Ejemplares similares

Ejemplares similares